Caring for the Ages
September 28, 2015
Showing 7361 - 7370 of 8630 results
JAMDA
April 2, 2021
Stroke Rehabilitation Use and Caregiver Psychosocial Health Profiles in Singapore: A Latent Profile Transition Analysis
To identify and describe caregiver profiles based on their psychosocial health characteristics over a 12-month period and transitions among these profiles, to determine if stroke rehabilitation use at 12 months post-stroke differed by caregiver profile transition patterns, and to investigate if caregiver p...
Caring for the Ages
March 2, 2015
Stroke Risk Climbs Sharply With More Risk Factors
JAMDA
February 9, 2015
Stroke-Related Sarcopenia: Specific Characteristics
Sarcopenia is characterized by muscle wasting and is primarily a disease of the elderly. A stroke-specific sarcopenia has been described recently. Stroke-related sarcopenia has a number of features that distinguish it from the age-related sarcopenia. The disability from stroke depends on the brain lesion l...
JAMDA
February 23, 2022
Strong Decay of SARS-CoV-2 Spike Antibodies after 2 BNT162b2 Vaccine Doses and High Antibody Response to a Third Dose in Nursing Home Residents
To measure the antibody decay after 2 BNT162b2 doses and the antibody response after a third vaccine dose administered 6 months after the second one in nursing home residents with and without prior COVID-19.
JAMDA
April 21, 2023
Stronger Impact of COVID-19 in Nursing Homes of a French Region During the Second Pandemic Wave
Quantify the effects of characteristics of nursing homes and their surroundings on the spread of COVID-19 outbreaks and assess the changes in resident protection between the first 2 waves (March 1 to July 31 and August 1 to December 31, 2020).
Sponsored Education
Feb 18, 2026 12:00 pm - Feb 18, 2026 1:00 pm
Stronger Shields for Seniors: Respiratory Protection with High-Dose Flu and Recombinant Protein non-mRNA COVID Vaccine Strategies
This webinar will explore evidence-based approaches to protecting respiratory health in LTC settings, with a focus on high dose influenza vaccine and a recombinant protein, non-mRNA COVID-19 vaccine option. Sanofi’s medical directors, Dr. Morgan Anderson and Dr. Katie Sharff, will share insights on the latest influenza vaccine pooled analysis FLUNITY-HD and discuss evolving data on the recombinant protein, non-mRNA COVID-19 vaccine. They will be joined by Dr. Chad Worz, CEO of the American Society of Consultant Pharmacists (ASCP), to provide expert perspectives on clinical implications and practical applications for elder care.
Read MoreBasic Page
Stronger Than Ever: The Pet-People Connection and Your Residents
JAMDA
April 27, 2023
Structural Inequities in Outcomes for Dually-Medicare/Medicaid Enrolled Assisted Living Residents
JAMDA
July 1, 2022
Structured Care Protocols for People Living With Dementia in Nursing Homes: Reflections for Research
